Recent Announcements
PhotoPharmics Welcomes Three Renowned Experts to Its Clinical & Scientific Advisory Board
PhotoPharmics, an innovator in light-based therapies for neurodegenerative diseases, proudly announces the appointment of three eminent experts to its Clinical & Scientific Advisory Board (CSAB). The new membersāDr. Charles H. Adler, Dr. George Brainard, and Dr. Robert A. Hauserābring unparalleled expertise to the advisory board, reinforcing PhotoPharmics’ mission to pioneer groundbreaking treatments for Parkinsonās disease and other neurodegenerative disorders.
āWe are honored to welcome Dr. Adler, Dr. Brainard, and Dr. Hauser to our Clinical & Scientific Advisory Board,ā said Kent Savage, CEO of PhotoPharmics. āTheir expertise and groundbreaking research are invaluable as we continue to develop our light-based therapies. These additions underscore our commitment to advancing innovative treatments that improve the lives of patients worldwide.ā
Featured Article
How Parkinson’s Affects Sleep and Vice-Versa
When most people think of Parkinsonās Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinsonās experience a wide range of non-motor symptoms that can often be more disruptive to their daily...
How Parkinson’s Affects Sleep and Vice-Versa
When most people think of Parkinsonās Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinsonās experience a wide range of non-motor symptoms that can often be more disruptive to their daily...
Problem displaying Facebook posts. Backup cache in use.
Click to show error
Archived Content